BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 14965441)

  • 1. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.
    Raaphorst FM; Meijer CJ; Fieret E; Blokzijl T; Mommers E; Buerger H; Packeisen J; Sewalt RA; Otte AP; van Diest PJ
    Neoplasia; 2003; 5(6):481-8. PubMed ID: 14965441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis.
    Breuer RH; Snijders PJ; Smit EF; Sutedja TG; Sewalt RG; Otte AP; van Kemenade FJ; Postmus PE; Meijer CJ; Raaphorst FM
    Neoplasia; 2004; 6(6):736-43. PubMed ID: 15720799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
    van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
    Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific expression of polycomb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomas.
    Raaphorst FM; Vermeer M; Fieret E; Blokzijl T; Dukers D; Sewalt RG; Otte AP; Willemze R; Meijer CJ
    Am J Pathol; 2004 Feb; 164(2):533-42. PubMed ID: 14742259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A panel of monoclonal antibodies against human polycomb group proteins.
    Hamer KM; Sewalt RG; den Blaauwen JL; Hendrix T; Satijn DP; Otte AP
    Hybrid Hybridomics; 2002 Aug; 21(4):245-52. PubMed ID: 12193277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma.
    Visser HP; Gunster MJ; Kluin-Nelemans HC; Manders EM; Raaphorst FM; Meijer CJ; Willemze R; Otte AP
    Br J Haematol; 2001 Mar; 112(4):950-8. PubMed ID: 11298590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast.
    Ding L; Kleer CG
    Cancer Res; 2006 Oct; 66(19):9352-5. PubMed ID: 17018586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.
    Balasubramanian S; Adhikary G; Eckert RL
    Carcinogenesis; 2010 Mar; 31(3):496-503. PubMed ID: 20015867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct BMI-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T cell differentiation.
    Raaphorst FM; Otte AP; van Kemenade FJ; Blokzijl T; Fieret E; Hamer KM; Satijn DP; Meijer CJ
    J Immunol; 2001 May; 166(10):5925-34. PubMed ID: 11342607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
    Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
    Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
    Silva J; García JM; Peña C; García V; Domínguez G; Suárez D; Camacho FI; Espinosa R; Provencio M; España P; Bonilla F
    Clin Cancer Res; 2006 Dec; 12(23):6929-36. PubMed ID: 17145810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer.
    Pietersen AM; Horlings HM; Hauptmann M; Langerød A; Ajouaou A; Cornelissen-Steijger P; Wessels LF; Jonkers J; van de Vijver MJ; van Lohuizen M
    Breast Cancer Res; 2008; 10(6):R109. PubMed ID: 19099573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.
    Xu F; Li X; Wu L; Zhang Q; Yang R; Yang Y; Zhang Z; He Q; Chang C
    Ann Hematol; 2011 Jun; 90(6):643-53. PubMed ID: 21125401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease.
    Raaphorst FM; van Kemenade FJ; Blokzijl T; Fieret E; Hamer KM; Satijn DP; Otte AP; Meijer CJ
    Am J Pathol; 2000 Sep; 157(3):709-15. PubMed ID: 10980109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
    Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
    Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma.
    van Kemenade FJ; Raaphorst FM; Blokzijl T; Fieret E; Hamer KM; Satijn DP; Otte AP; Meijer CJ
    Blood; 2001 Jun; 97(12):3896-901. PubMed ID: 11389032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
    Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
    Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens.
    Steele JC; Torr EE; Noakes KL; Kalk E; Moss PA; Reynolds GM; Hubscher SG; van Lohuizen M; Adams DH; Young LS
    Br J Cancer; 2006 Nov; 95(9):1202-11. PubMed ID: 17024127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues.
    Ding L; Erdmann C; Chinnaiyan AM; Merajver SD; Kleer CG
    Cancer Res; 2006 Apr; 66(8):4095-9. PubMed ID: 16618729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.